Optiflow in Sequential Non-Invasive Ventilation

NACompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

June 25, 2015

Primary Completion Date

February 5, 2019

Study Completion Date

March 5, 2019

Conditions
Respiratory Failure
Interventions
DEVICE

Optiflow

"Patients receive high flow oxygen delivery system, Optiflow, conventional clinical management and sequential used of NIV for a period of 36 hours at least.~High flow oxygen nasal therapy (Optiflow) : The flow will be set at 40l/min to 60l/min The inspired fraction of oxygen (FiO2) is the same as that defined at the end of VNI session and may be adjusted in order to obtain a SaO2 between 94% and 98%."

DEVICE

Conventional oxygen therapy

Patients receive conventional oxygen therapy with high concentration mask, conventional clinical management, and sequential use of NIV Conventional oxygen therapy: The inspired fraction of oxygen (FiO2) is the same as that defined at the end of VNI session and may be adjusted in order to obtain a Arterial Oxygen Saturation (SaO2) between 94% and 98%.

Trial Locations (8)

24000

Service de Réanimation - CH de Perigueux, Périgueux

31059

Service de Réanimation Polyvalente - CHU de Toulouse, Toulouse

33000

Service de réanimation médicale - CHU de Bordeaux, Bordeaux

33505

Service de Réanimation Polyvalente - CH de Libourne, Libourne

40024

Réanimation Polyvalente - CH de Mont de Marsan, Mont-de-Marsan

47923

Service de Réanimation Polyvalente - CH d'Agen, Agen

64100

Service de réanimation - CH de la côte basque, Bayonne

81000

Réanimation polyvalente - CH d'Albi, Albi

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02389166 - Optiflow in Sequential Non-Invasive Ventilation | Biotech Hunter | Biotech Hunter